tiprankstipranks
Trending News
More News >
PACS Group Inc (PACS)
NYSE:PACS
US Market

PACS Group Inc (PACS) Earnings Dates, Call Summary & Reports

Compare
253 Followers

Earnings Data

Report Date
May 18, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.4
Last Year’s EPS
0.42
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized record financial results, strong clinical improvements, high mature-facility occupancy, low leverage and constructive 2026 guidance — offset by expected short-term headwinds related to cost increases, cohort stabilization of recently acquired facilities (lower occupancy in ramping/new cohorts), and elevated M&A pricing. Overall, management presents a confident, disciplined growth story with measurable operational wins and conservative capital management, acknowledging transitional pressures in non‑mature assets.
Company Guidance
For full-year 2026 PACS guided revenue of $5.65–$5.75 billion (midpoint ~$5.70B, roughly +8% vs. 2025 revenue of $5.29B) and adjusted EBITDA of $555–$575 million (midpoint $565M, roughly +12% vs. 2025 adjusted EBITDA of $505M); the outlook incorporates assumptions of steady organic growth, margin expansion from improved occupancy and skilled mix, stable reimbursement, disciplined capital allocation and a nominal M&A cadence (modeled at about 5 facility acquisitions per quarter, ~20/year, typically acquired at ~60–70% occupancy with effectively 0% initial margin), and reflects that the company entered 2026 with a scaled platform and a conservatively leveraged balance sheet (year-end 2025 net leverage ≈0.3x).
Record Revenue and Profitability
Full year 2025 revenue of $5.29B, up ~29% year-over-year; Q4 revenue of $1.36B, up ~12% year-over-year. Full year net income $191.5M and diluted EPS $1.22. Record adjusted EBITDAR of $883.9M and adjusted EBITDA of $505M for 2025 (Q4 adjusted EBITDAR $237.7M; Q4 adjusted EBITDA $142.1M).
Strong Guidance for 2026
2026 revenue guidance $5.65B–$5.75B (midpoint ~$5.7B), ~8% growth vs 2025; adjusted EBITDA guidance $555M–$575M (midpoint $565M), ~12% growth vs 2025 midpoint — signaling expected continued margin expansion.
High and Improving Clinical Quality
207 facilities (73.4% of portfolio) rated 4 or 5 stars on CMS quality measures. Average CMS QM star rating in mature facilities rose to 4.4 in 2025 from 4.3 in 2024, well above industry average (~3.5).
Strong Occupancy in Mature Portfolio
Overall portfolio occupancy averaged 89.1% for 2025; mature facilities delivered 94.9% occupancy (up 0.5 percentage points from 94.4% in prior year), demonstrating consistent demand and operational performance.
Scale and Platform Footprint
At year-end 2025 PACS operated 321 facilities across 17 states with 35,379 total operating beds (32,854 skilled nursing beds; 2,525 assisted living beds), caring for >31,700 patients daily and supported by >47,000 employees.
Disciplined Balance Sheet and Low Leverage
Year-end net leverage approximately 0.3x despite significant acquisition and capital activity; deployed >$145M in quarter for real estate and other investments while maintaining conservative leverage.
Successful Integration and Operational Wins
Completed 8 strategic acquisitions in 2025 (all in existing markets) and continued integration of 2024 acquisitions. Notable operational outcomes include 7 zero-deficiency surveys in 2025 and a de novo Oceanside, CA facility achieving profitability in its first year with >250 admissions in 2025.
Growing Real Estate Ownership and Long Lease Profiles
Now wholly or partially own real estate interests in 102 facilities. Average remaining lease terms: ~13 years for operating leases and ~22 years for finance leases, enabling long-term stability and purchase option strategies to reduce lease-adjusted leverage.

PACS Group Inc (PACS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PACS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 18, 2026
2026 (Q1)
0.40 / -
0.42
Feb 26, 2026
2025 (Q4)
0.46 / 0.51
0.39129.16% (+0.11)
Nov 19, 2025
2025 (Q3)
0.45 / 0.32
0.354-9.60% (-0.03)
Aug 18, 2025
2025 (Q2)
0.39 / 0.47
0.56-16.96% (-0.10)
May 19, 2025
2025 (Q1)
0.42 / 0.42
0.3811.58% (+0.04)
Nov 07, 2024
2024 (Q3)
0.34 / 0.34
Aug 12, 2024
2024 (Q2)
0.35 / 0.56
0.139302.88% (+0.42)
May 13, 2024
2024 (Q1)
0.29 / 0.38
1.526-75.10% (-1.15)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PACS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
$41.67
Nov 19, 2025
$16.83$26.14+55.32%
Aug 18, 2025
$11.50$11.41-0.78%
May 19, 2025
$10.81$10.65-1.48%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does PACS Group Inc (PACS) report earnings?
PACS Group Inc (PACS) is schdueled to report earning on May 18, 2026, After Close (Confirmed).
    What is PACS Group Inc (PACS) earnings time?
    PACS Group Inc (PACS) earnings time is at May 18, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PACS EPS forecast?
          PACS EPS forecast for the fiscal quarter 2026 (Q1) is 0.4.